Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation

Fig. 2

The cumulative incidence rate (CIR) of EBV infection in allo-HSCT patients according to the score system in the derivation and validation groups. High risk represents patients with scores of 8 to 11, intermediate risk represents patients with scores of 5 to 6, and low risk represents patients with scores of 0 to 3. A CIR of EBV infection in the derivation cohort (log-rank test, p < 0.001). B CIR of EBV infection in the validation cohort (log-rank test, p < 0.001)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us